Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Baxter
Merck
Harvard Business School
Citi
Mallinckrodt
Cipla
AstraZeneca
Covington

Generated: December 15, 2018

DrugPatentWatch Database Preview

CLADRIBINE Drug Profile

« Back to Dashboard

Drug patent expirations by year for CLADRIBINE
Pharmacology for CLADRIBINE
Medical Subject Heading (MeSH) Categories for CLADRIBINE
Synonyms for CLADRIBINE
(2R,3S,5R)-5-(6-amino-2-chloro-9-purinyl)-2-(hydroxymethyl)-3-oxolanol
(2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
(2R,3S,5R)-5-(6-amino-2-chloro-9H-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol
(2R,3S,5R)-5-(6-amino-2-chloro-purin-9-yl)-2-(hydroxymethyl)tetrahydrofuran-3-ol
(2R,3S,5R)-5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxalan-3-ol
(2R,3S,5R)-5-(6-amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
(2R,3S,5R)-5-(6-azanyl-2-chloranyl-purin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
2 Chlorodeoxyadenosine
2-CdA
2-chloro-2'-deoxy-adenosine
2-Chloro-2'-deoxy-beta-adenosine
2-Chloro-2'-deoxyadenosine
2-Chloro-2'-deoxyadenosine, antileukemic
2-chloro-6-amino-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine
2-Chloro-6-amino-9-(2-deoxy-beta-D-erythropentofuranosyl)purine
2-chloro-deoxyadenosine
2-Chlorodeoxyadenosine
2'-Deoxy-2-chloroadenosine
24757-90-2
291C638
2CdA
2ClAdo
4291-63-8
47M74X9YT5
5542-92-7
6-amino-2-chloro-9-(2-deoxy-beta-D-erythro-pentofuranosyl)purine
6-amino-2-chloro-9-(2-deoxy-beta-erythropentofuranosyl)purine
A826062
AB0011806
AB00382963_19
AB00382963-17
AC-7591
AC1L2FXP
ACT02615
Adenosine, 2-chloro-2'-deoxy
ADENOSINE, 2-CHLORO-2'-DEOXY-
AJ-45639
AK-46529
AKOS015854898
AKOS015892544
AS-12366
AX8000129
BCP9000538
BDBM38920
BR-46529
BRN 0624220
C-17986
C10H12ClN5O3.C3H8
CAS-4291-63-8
CC-25898
CC0168
CCG-101116
CCRIS 9374
CHEBI:567361
CHEMBL1619
Chlorodeoxyadenosine
cid_20279
CJ-10765
CL9
Cladarabine
Cladaribine
Cladiribine
cladribina
Cladribine (JAN/USAN/INN)
Cladribine [USAN:INN:BAN]
Cladribine [USAN:USP:INN:BAN]
Cladribine for peak identification, European Pharmacopoeia (EP) Reference Standard
Cladribine, European Pharmacopoeia (EP) Reference Standard
Cladribine, United States Pharmacopeia (USP) Reference Standard
cladribinum
CldAdo
CPD000058553
CS-2057
CTK8D4033
D01370
D05GJW
DB00242
DR001033
DSSTox_CID_2828
DSSTox_GSID_22828
DSSTox_RID_76747
DTXSID8022828
FT-0080707
GTPL4799
HMS2052K13
HMS2232C23
HSDB 7564
HY-13599
KB-22050
Leustat
Leustatin
Leustatin (TN)
Leustatin, 2-chlorodeoxyadenosine, Cladribine
Leustatin|||2-Chloro-2'-deoxyadenosine|||2-CdA|||NSC-105014-F|||(2R,3S,5R)-5-(6-Amino-2-chloropurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol
Litak
LS-15109
mavenclad
MFCD00153939
MLS000028377
MLS000028484
MLS000759397
MLS001077345
MLS001424194
MolPort-005-935-074
Movectro
Mylinax
NC00366
NCGC00018167-03
NCGC00022567-05
NCGC00022567-06
NCGC00022567-07
NCGC00022567-08
NCGC00164384-01
NCGC00254518-01
NSC 105014
NSC 105014-F
NSC-105014
NU001578
NU004670
Opera_ID_1191
PTOAARAWEBMLNO-KVQBGUIXSA-N
RTC-063884
RWJ 26251
RWJ-26251
RWJ-26251-000
S-7479
S1199
SAM001246526
SC-17356
SCHEMBL3775
SMR000058553
SR-01000003063
SR-01000003063-10
ST2409775
TC-063884
Tox21_110834
Tox21_300596
UNII-47M74X9YT5
ZINC3798064

US Patents and Regulatory Information for CLADRIBINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fresenius Kabi Usa CLADRIBINE cladribine INJECTABLE;INJECTION 076571-001 Apr 22, 2004 AP RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Labs Ltd CLADRIBINE cladribine INJECTABLE;INJECTION 200510-001 Oct 6, 2011 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
West-ward Pharms Int CLADRIBINE cladribine INJECTABLE;INJECTION 075405-001 Feb 28, 2000 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Baxter
Merck
Harvard Business School
Citi
Mallinckrodt
Cipla
AstraZeneca
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.